Search research articles
Contact Us
Filters
Showing results (31-40 of 111) with videos related to
Page
of 12
Sort By:
The Journal of Biological Chemistry
|
March 12, 2014
Rapid degradation of the complement regulator, CD59, by a novel inhibitor
Bishuang Cai, Shuwei Xie, Fengming Liu, et al.
American Journal of Physiology. Renal Physiology
|
October 12, 2023
Generation of <i>Atp6v1g3</i>-Cre mice for investigation of intercalated cells and the collecting duct
Vijay Saxena, Samuel Arregui, Shaobo Zhang, et al.
Discover Oncology
|
November 6, 2024
LINC02466 promotes the progression of hepatocellular carcinoma through the mTOR pathway
Shiqian Liu, Zhipeng Quan, Jiaming Liang, et al.
Experimental Physiology
|
August 25, 2025
Exercise-induced effects on atherogenesis and tryptophan catabolism via the kynurenine pathway in an HIV-associated atherosclerosis mouse model
Marcus V S Rangel, Mohammad Afaque Alam, Mohammad Islamuddin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 16, 2011
rILYd4, a human CD59 inhibitor, enhances complement-dependent cytotoxicity of ofatumumab against rituximab-resistant B-cell lymphoma cells and chronic lymphocytic leukemia
Xiaowen Ge, Lin Wu, Weiguo Hu, et al.
The Journal of Biological Chemistry
|
March 25, 2010
Embryonic lethal abnormal vision-like HuR-dependent mRNA stability regulates post-transcriptional expression of cyclin-dependent kinase inhibitor p27Kip1
Gudrun Ziegeler, Jie Ming, Jana C Koseki, et al.
International Journal of Molecular Sciences
|
August 29, 2024
The Association between IL-1β and IL-18 Levels, Gut Barrier Disruption, and Monocyte Activation during Chronic Simian Immunodeficiency Virus Infection and Long-Term Suppressive Antiretroviral Therapy
Siva Thirugnanam, Chenxiao Wang, Chen Zheng, et al.
Frontiers in Oncology
|
February 5, 2021
TDO2 Promotes the EMT of Hepatocellular Carcinoma Through Kyn-AhR Pathway
Lei Li, Tao Wang, Shanbao Li, et al.
Oncology Letters
|
November 30, 2016
Adenovirus-mediated interleukin 21 gene transfer enhances antitumor immunity and reduces tumorigenicity of Hepa1-6 in mice
Jiyu Ju, Lina Wang, Dalin Di, et al.
Diabetes
|
September 28, 2004
Glycation inactivation of the complement regulatory protein CD59: a possible role in the pathogenesis of the vascular complications of human diabetes
Xuebin Qin, Allison Goldfine, Nicole Krumrei, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 111) with videos related to
Sort By:
Page
of 12
The Journal of Biological Chemistry
|
March 12, 2014
Rapid degradation of the complement regulator, CD59, by a novel inhibitor
Bishuang Cai, Shuwei Xie, Fengming Liu, et al.
American Journal of Physiology. Renal Physiology
|
October 12, 2023
Generation of <i>Atp6v1g3</i>-Cre mice for investigation of intercalated cells and the collecting duct
Vijay Saxena, Samuel Arregui, Shaobo Zhang, et al.
Discover Oncology
|
November 6, 2024
LINC02466 promotes the progression of hepatocellular carcinoma through the mTOR pathway
Shiqian Liu, Zhipeng Quan, Jiaming Liang, et al.
Experimental Physiology
|
August 25, 2025
Exercise-induced effects on atherogenesis and tryptophan catabolism via the kynurenine pathway in an HIV-associated atherosclerosis mouse model
Marcus V S Rangel, Mohammad Afaque Alam, Mohammad Islamuddin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 16, 2011
rILYd4, a human CD59 inhibitor, enhances complement-dependent cytotoxicity of ofatumumab against rituximab-resistant B-cell lymphoma cells and chronic lymphocytic leukemia
Xiaowen Ge, Lin Wu, Weiguo Hu, et al.
The Journal of Biological Chemistry
|
March 25, 2010
Embryonic lethal abnormal vision-like HuR-dependent mRNA stability regulates post-transcriptional expression of cyclin-dependent kinase inhibitor p27Kip1
Gudrun Ziegeler, Jie Ming, Jana C Koseki, et al.
International Journal of Molecular Sciences
|
August 29, 2024
The Association between IL-1β and IL-18 Levels, Gut Barrier Disruption, and Monocyte Activation during Chronic Simian Immunodeficiency Virus Infection and Long-Term Suppressive Antiretroviral Therapy
Siva Thirugnanam, Chenxiao Wang, Chen Zheng, et al.
Frontiers in Oncology
|
February 5, 2021
TDO2 Promotes the EMT of Hepatocellular Carcinoma Through Kyn-AhR Pathway
Lei Li, Tao Wang, Shanbao Li, et al.
Oncology Letters
|
November 30, 2016
Adenovirus-mediated interleukin 21 gene transfer enhances antitumor immunity and reduces tumorigenicity of Hepa1-6 in mice
Jiyu Ju, Lina Wang, Dalin Di, et al.
Diabetes
|
September 28, 2004
Glycation inactivation of the complement regulatory protein CD59: a possible role in the pathogenesis of the vascular complications of human diabetes
Xuebin Qin, Allison Goldfine, Nicole Krumrei, et al.
Page
of 12